These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22983196)

  • 1. IGF2BP1: a post-transcriptional "driver" of tumor cell migration.
    Stöhr N; Hüttelmaier S
    Cell Adh Migr; 2012; 6(4):312-8. PubMed ID: 22983196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling.
    Stöhr N; Köhn M; Lederer M; Glass M; Reinke C; Singer RH; Hüttelmaier S
    Genes Dev; 2012 Jan; 26(2):176-89. PubMed ID: 22279049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG).
    Zirkel A; Lederer M; Stöhr N; Pazaitis N; Hüttelmaier S
    Nucleic Acids Res; 2013 Jul; 41(13):6618-36. PubMed ID: 23677615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma.
    Alam R; Schultz CR; Golembieski WA; Poisson LM; Rempel SA
    Neuro Oncol; 2013 Apr; 15(4):451-61. PubMed ID: 23382286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors.
    Müller S; Bley N; Glaß M; Busch B; Rousseau V; Misiak D; Fuchs T; Lederer M; Hüttelmaier S
    Nucleic Acids Res; 2018 Jul; 46(12):6285-6303. PubMed ID: 29660014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of a human DnaJ protein hTid-1S correlates with aberrant actin cytoskeleton organization in lesional psoriatic skin.
    Choi JH; Choi DK; Sohn KC; Kwak SS; Suk J; Lim JS; Shin I; Kim SW; Lee JH; Joe CO
    J Biol Chem; 2012 Jul; 287(31):25954-63. PubMed ID: 22692211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation.
    Shin KD; Lee MY; Shin DS; Lee S; Son KH; Koh S; Paik YK; Kwon BM; Han DC
    J Biol Chem; 2005 Dec; 280(50):41439-48. PubMed ID: 16234246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKA-induced F-actin rearrangement requires phosphorylation of Hsp27 by the MAPKAP kinase MK5.
    Kostenko S; Johannessen M; Moens U
    Cell Signal; 2009 May; 21(5):712-8. PubMed ID: 19166925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia.
    Stoskus M; Vaitkeviciene G; Eidukaite A; Griskevicius L
    Blood Cells Mol Dis; 2016 Mar; 57():30-4. PubMed ID: 26852652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sec6 enhances cell migration and suppresses apoptosis by elevating the phosphorylation of p38 MAPK, MK2, and HSP27.
    Tanaka T; Iino M; Goto K
    Cell Signal; 2018 Sep; 49():1-16. PubMed ID: 29729335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
    Bell JL; Wächter K; Mühleck B; Pazaitis N; Köhn M; Lederer M; Hüttelmaier S
    Cell Mol Life Sci; 2013 Aug; 70(15):2657-75. PubMed ID: 23069990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp27 silencing coordinately inhibits proliferation and promotes Fas-induced apoptosis by regulating the PEA-15 molecular switch.
    Hayashi N; Peacock JW; Beraldi E; Zoubeidi A; Gleave ME; Ong CJ
    Cell Death Differ; 2012 Jun; 19(6):990-1002. PubMed ID: 22179576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer.
    Vahid S; Thaper D; Gibson KF; Bishop JL; Zoubeidi A
    Sci Rep; 2016 Aug; 6():31842. PubMed ID: 27555231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MK2 SUMOylation regulates actin filament remodeling and subsequent migration in endothelial cells by inhibiting MK2 kinase and HSP27 phosphorylation.
    Chang E; Heo KS; Woo CH; Lee H; Le NT; Thomas TN; Fujiwara K; Abe J
    Blood; 2011 Feb; 117(8):2527-37. PubMed ID: 21131586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 14-3-3epsilon inhibits MK5-mediated cell migration by disrupting F-actin polymerization.
    Tak H; Jang E; Kim SB; Park J; Suk J; Yoon YS; Ahn JK; Lee JH; Joe CO
    Cell Signal; 2007 Nov; 19(11):2379-87. PubMed ID: 17728103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of heat shock protein 27 on extravillous trophoblast differentiation and on eukaryotic translation initiation factor 4E expression.
    Sadeh-Mestechkin D; Epstein Shochet G; Pomeranz M; Fishman A; Drucker L; Biron-Shental T; Lishner M; Tartakover Matalon S
    Mol Hum Reprod; 2014 May; 20(5):422-32. PubMed ID: 24431103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer.
    Bley N; Schott A; Müller S; Misiak D; Lederer M; Fuchs T; Aßmann C; Glaß M; Ihling C; Sinz A; Pazaitis N; Wickenhauser C; Vetter M; Ungurs O; Strauss HG; Thomssen C; Hüttelmaier S
    RNA Biol; 2021 Mar; 18(3):391-403. PubMed ID: 32876513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the SPARC acidic domain or EGF-like module reduces SPARC-induced migration and signaling through p38 MAPK/HSP27 in glioma.
    McClung HM; Golembieski WA; Schultz CR; Jankowski M; Schultz LR; Rempel SA
    Carcinogenesis; 2012 Feb; 33(2):275-84. PubMed ID: 22114076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTORC2 deploys the mRNA binding protein IGF2BP1 to regulate c-MYC expression and promote cell survival.
    Lambrianidou A; Sereti E; Soupsana K; Komini C; Dimas K; Trangas T
    Cell Signal; 2021 Apr; 80():109912. PubMed ID: 33388443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer.
    Müller S; Bley N; Busch B; Glaß M; Lederer M; Misiak C; Fuchs T; Wedler A; Haase J; Bertoldo JB; Michl P; Hüttelmaier S
    Nucleic Acids Res; 2020 Sep; 48(15):8576-8590. PubMed ID: 32761127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.